BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14586645)

  • 1. Differential alterations of the genes in the CDKN2A-CCND1-CDK4-RB1 pathway are associated with the development of head and neck squamous cell carcinoma in Indian patients.
    Tripathi Bhar A; Banerjee S; Chunder N; Roy A; Sengupta A; Roy B; Roychowdhury S; Panda CK
    J Cancer Res Clin Oncol; 2003 Nov; 129(11):642-50. PubMed ID: 14586645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of deletion in the chromosomal 8p21.3-23 region with the development of invasive head & neck squamous cell carcinoma in Indian patients.
    Bhattacharya N; Tripathi A; Dasgupta S; Sabbir MG; Roy A; Sengupta A; Roy B; Roychowdhury S; Panda CK
    Indian J Med Res; 2003 Aug; 118():77-85. PubMed ID: 14680203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.
    Ichimura K; Schmidt EE; Goike HM; Collins VP
    Oncogene; 1996 Sep; 13(5):1065-72. PubMed ID: 8806696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
    Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: clinical and prognostic implications.
    Ghosh S; Ghosh A; Maiti GP; Mukherjee N; Dutta S; Roy A; Roychoudhury S; Panda CK
    Mol Cancer; 2010 Mar; 9():58. PubMed ID: 20226061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the pRb pathway in 2',3'-dideoxycytidine- and 1, 3-butadiene-induced mouse lymphomas.
    Zhuang SM; Wiseman RW; Söderkvist P
    Cancer Lett; 2000 May; 152(2):129-34. PubMed ID: 10773403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicoprognostic significance of pRb1 pathway alterations in uterine endometrial adenocarcinoma.
    Semczuk A; Cybulski M; Tomaszewski J; Rechberger T; Jakowicki JA
    Cancer Genet Cytogenet; 2004 Oct; 154(2):186-9. PubMed ID: 15474160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
    Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.
    Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK
    J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of p16 genetic alterations in head and neck tumours.
    Miracca EC; Kowalski LP; Nagai MA
    Br J Cancer; 1999 Oct; 81(4):677-83. PubMed ID: 10574255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour.
    Sabbir MG; Roy A; Mandal S; Dam A; Roychoudhury S; Panda CK
    Int J Exp Pathol; 2006 Apr; 87(2):151-61. PubMed ID: 16623759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
    Burns KL; Ueki K; Jhung SL; Koh J; Louis DN
    J Neuropathol Exp Neurol; 1998 Feb; 57(2):122-30. PubMed ID: 9600204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential deletions in 3p are associated with the development of head and neck squamous cell carcinoma in Indian patients.
    Chakraborty SB; Dasgupta S; Roy A; Sengupta A; Ray B; Roychoudhury S; Panda CK
    Cancer Genet Cytogenet; 2003 Oct; 146(2):130-8. PubMed ID: 14553947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a.
    Waber P; Dlugosz S; Cheng QC; Truelson J; Nisen PD
    Oncogene; 1997 Oct; 15(14):1699-704. PubMed ID: 9349503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pituitary adenomas infrequently contain inactivation of retinoblastoma 1 gene and activation of cyclin dependent kinase 4 gene.
    Honda S; Tanaka-Kosugi C; Yamada S; Sano T; Matsumoto T; Itakura M; Yoshimoto K
    Endocr J; 2003 Jun; 50(3):309-18. PubMed ID: 12940460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.
    Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C
    Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.